The severe hypercholesterolemia phenotype: clinical diagnosis, management, and emerging therapies.
about
Unmet Needs in LDL-C Lowering: When Statins Won't Do!LDL cholesterol, statins and PCSK 9 inhibitorsChallenges in the Diagnosis and Treatment of Homozygous Familial HypercholesterolemiaOptimizing Treatment of Familial Hypercholesterolemia in Children and AdolescentsClinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service.Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials.Antisense inhibition of apolipoprotein (a) to lower plasma lipoprotein (a) levels in humansLong-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype.Generation of Human Liver Chimeric Mice with Hepatocytes from Familial Hypercholesterolemia Induced Pluripotent Stem Cells.AAV-mediated gene therapy for atherosclerosis.The role of antisense oligonucleotide therapy in patients with familial hypercholesterolemia: risks, benefits, and management recommendations.Recommendations for the management of patients with familial hypercholesterolemia.PCSK9 inhibition: current concepts and lessons from human genetics.Targeting lipoprotein (a): an evolving therapeutic landscape.Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9.Therapeutic Potential and Critical Analysis of the PCSK9 Monoclonal Antibodies Evolocumab and Alirocumab.Evolocumab: A Review in Hyperlipidemia.Genetics of Dyslipidemia and Ischemic Heart Disease.Effect of hypercholesterolaemia on myocardial function, ischaemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy.Role of Coronary Calcium for Risk Stratification and Prognostication.Dyslipidemias and Cardiovascular Prevention: Tailoring Treatment According to Lipid Phenotype.Antihypercholesterolemic Effects of Fruit Aqueous Extract of Copernicia prunifera (Miller) H. E. Moore in Mice Diet-Induced Hypercholesterolemia.Biological Effect of Cynara cardunculus on Kidney Status of Hypercholesterolemic Rats.Lipid profiles and determinants of total cholesterol and hypercholesterolaemia among 25-74 year-old urban and rural citizens of the Yangon Region, Myanmar: a cross-sectional study.Circulating progenitor cells in patients with familial hypercholesterolemia.Clinical Application of Genetic Testing in Heart Failure.Familial hypercholesterolemia in very young myocardial infarction.Design of a Controlled Trial of Cascade Screening for Hypercholesterolemia: The (CASH) Study
P2860
Q26741705-7D7ADE67-FC4B-4866-8D52-CAD1923217C1Q26782522-8918F35F-F30B-4910-9038-029E59394169Q26787050-5919621A-2288-4AFB-B986-EF62C6F8E96EQ26798119-5DC4A4E0-1825-4D24-9427-E533841FB0B1Q31161044-D33F1CE2-A052-4F1D-B515-6F20F18C2F8BQ35130714-D75AEFE7-9F2A-4C4D-820F-0DC120587243Q36617508-15DBAC9E-6DE0-49B8-B486-7AF5025BF9FAQ37066247-6FA18D32-E075-47A8-AD9C-A9A0261FDF4AQ37707720-99662660-A630-4277-A1D9-949D9E1B3D19Q38236204-AA4C21E2-E156-4CB3-A510-A4FCE148707EQ38268342-DC722374-194C-41D7-95FE-DD30347FC5E5Q38268915-E86CBFFC-1E4B-4DA4-A9BA-D0FD1C3ED989Q38338236-3054C1FA-E3B7-48C2-BB30-B4EEE15DC43BQ38367355-DAE49755-D1E2-4A13-8F2A-A6E5D84C55E1Q38424373-B038CC44-E23E-4DD2-BEFE-F4C6B22E40E4Q38596398-9C4AEE44-FE2B-4087-B71A-121F3C60245DQ38661399-FF068883-0EA0-4E0E-8D0A-64144142EFF2Q38692446-CC03FB30-F7B4-48E8-B5C7-E9307DCFEE06Q38773916-1518B438-E49F-450E-B756-0C5A86665C3EQ38825525-D73A3100-7A7E-4E71-B160-9B63DE57742CQ38919261-B5D81AB7-FB47-41F0-9C39-7D63FD06BE62Q39320394-B706A787-123F-48C9-8D99-63185759486FQ42580861-97E6F389-ACCE-4F32-B52E-0A4B5F947EFEQ47094983-C4CDF5CE-3FE3-432F-A21D-3F36F81C852BQ47146490-5D386A9F-59F5-4EDB-A649-E625AE78D321Q47635650-CE470FA1-42CE-40B0-BCD1-A68229035EB6Q50074149-4BCB9C81-CF6A-4C30-9290-9D3C2201FCD9Q55330259-5E586C6E-9C1B-4EFA-B00E-F2567B512E2FQ58710131-634EFAAD-DD3E-44DE-B689-47CE82547264
P2860
The severe hypercholesterolemia phenotype: clinical diagnosis, management, and emerging therapies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The severe hypercholesterolemi ...... ement, and emerging therapies.
@en
type
label
The severe hypercholesterolemi ...... ement, and emerging therapies.
@en
prefLabel
The severe hypercholesterolemi ...... ement, and emerging therapies.
@en
P1476
The severe hypercholesterolemi ...... ement, and emerging therapies.
@en
P2093
Allan D Sniderman
Sergio Fazio
P304
P356
10.1016/J.JACC.2014.01.060
P407
P577
2014-03-12T00:00:00Z